Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000197

President and CEO sold 2,260 shares at $23.79 ($53,765)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2024-08-20 Sale −2,260 $23.79 $53,765 235,807 D
Open-market sales · 2,260 sh · avg $23.79 · $53,765
Loading xslF345X05/wk-form4_1724357777.xml…